FCCL supplier Taiflex Scientific expects its revenues to grow 10.5% sequentially and 2.2% on year to NT$2.6-3.3 billion (US$86.78-110.14 million) in the third quarter of 2014, with a gross margin of 21-25% and operating margin of 11-15%.
The article requires paid subscription. Subscribe Now